Global Nuclear Cardiovascular Imaging Market
The global cardiovascular information systems market is expected to reach USD 917 million by 2020 from USD 621 million in 2015, growing at rate CAGR of 8.1%. Better interoperability, remote access to images and data, reduced IT burden in medical centres are the driving factors of CVIS market.
Evaluation of images is currently carried out visually by the wall motion abnormalities in combination with presence of late hyper enhancement on late contrast enhanced magnetic resonance. The captured images are compared with the reference images in the cine sequence using a recognised image processing techniques.
The technology offers major advantages in terms of its speed and accuracy to detect reversible myocardial infract or myocardial viability, and reduces the dependence of the clinician - muscle motion during systole can be monitored. The standalone software can be integrated with existing nuclear imaging equipment.
With a density of MRI scans per million population of ~46% Japan is one of the largest markets for medical imaging. Europe and Asia Pacific are projected to grow at a significant rate due to large consumer base, initiatives for enhancing healthcare infrastructure.
The leading manufacturers of medical imaging equipment market are GE Healthcare, Philips and Siemens which generates more than 3 quarters of the imaging equipment revenue. This study is focused to understanding market of nuclear cardiac imaging equipment and image quantification software. Nuclear cardiology imaging equipment includes PET & SPECT (gamma camera).
This report targets nuclear image analysis software markets in Asia & Europe. SkyQuest’s team engaged in an in-depth global research towards understanding players in the market, market size and regulatory requirements of similar modalities in Asian and European region. An analysis of this market was done to give insights on the market attractiveness and regions to initiate commercialization.
Evaluation of images is currently carried out visually by the wall motion abnormalities in combination with presence of late hyper enhancement on late contrast enhanced magnetic resonance. The captured images are compared with the reference images in the cine sequence using a recognised image processing techniques.
The technology offers major advantages in terms of its speed and accuracy to detect reversible myocardial infract or myocardial viability, and reduces the dependence of the clinician - muscle motion during systole can be monitored. The standalone software can be integrated with existing nuclear imaging equipment.
With a density of MRI scans per million population of ~46% Japan is one of the largest markets for medical imaging. Europe and Asia Pacific are projected to grow at a significant rate due to large consumer base, initiatives for enhancing healthcare infrastructure.
The leading manufacturers of medical imaging equipment market are GE Healthcare, Philips and Siemens which generates more than 3 quarters of the imaging equipment revenue. This study is focused to understanding market of nuclear cardiac imaging equipment and image quantification software. Nuclear cardiology imaging equipment includes PET & SPECT (gamma camera).
This report targets nuclear image analysis software markets in Asia & Europe. SkyQuest’s team engaged in an in-depth global research towards understanding players in the market, market size and regulatory requirements of similar modalities in Asian and European region. An analysis of this market was done to give insights on the market attractiveness and regions to initiate commercialization.
1. GLOBAL SCENARIO
2. INDUSTRY ACTIVITY
3. COMPETITIVE SCENARIO
4. SOFTWARE FROM ACADEMIA
5. INDIVIDUAL MARKET OVERVIEW
2. INDUSTRY ACTIVITY
3. COMPETITIVE SCENARIO
4. SOFTWARE FROM ACADEMIA
5. INDIVIDUAL MARKET OVERVIEW
